Stability Evaluation of National Reference Standards for Blood Products in Korea |
Park, Tae Jun
(Biologics Research Division, National Institute of Food and Drug Safety Evaluation)
Choi, Chan Woong (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Oh, Ho Kyung (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Kim, Jae Ok (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Kim, Byung Kuk (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Kang, Hyun Kyung (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Kwon, Eun Jeong (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Gweon, Eun Jeong (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Park, Sang Jin (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) Kang, Ho Il (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Jung, Ki Kyung (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Park, Sang Mi (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Kim, Ji Hye (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Han, Ki Won (Blood Products Division, National Institute of Food and Drug Safety Evaluation) Jeong, Ja Young (Biologics Research Division, National Institute of Food and Drug Safety Evaluation) |
1 | Knezevic, I. (2009) Stability evaluation of vaccines: WHO approach. Biologicals, 37, 357-359. DOI |
2 | World Health Organization (2011) WHO manual for the establishment of national and other secondary standards of vaccines (Ordering code: WHO/IVB/11.03), WHO, Geneva. |
3 | World Health Organization (1992) Annex 2: Guidelines for national authorities on quality assurance for biological products (WHO Technical Report Series, No. 822), WHO. |
4 | ICH (2003) Stability testing of new drug substances and products, Q1A(R2), step 4, ICH. |
5 | Epstein, J.S. (2012) Best practices in regulation of blood and blood products. Biologicals, 40, 200-204. DOI |
6 | Raut, S. and Hubbard, A.R. (2010) International reference standards in coagulation. Biologicals, 38, 423-429. DOI |
7 | World Health Organization, Regional Office for the Eastern Mediterranean (2006) Draft regional guidelines on stability testing of active substances and pharmaceutical products (Gov't Doc #: EM/RC53/R.12), WHO. |
8 | NIBSC (2012) Guidance document for the production, characterization and value assignment of biological reference materials, Materials document serial, NIBSC. |
9 | Kang, H.N., Lee, S.H., Kim, S.N., Hong, C.M., Lee, S.H. and Hong, S.H. (2006) A collaborative study to establish a Korea national biological standard for antithrombin concentrate. Thromb. Res., 117, 591-596. DOI |
10 | Kang, H.N., Kim, S.N., Lee, S.H. and Hong, S.H. (2004) A collaborative study to establish a Korean Standard for factor VIII: C concentrate. Thromb. Res., 113, 261-267. DOI |
11 | Kim, H., Shin, A.R., Chung, H.H., Kim, M.K., Lee, J.S., Shim, J.J. and Kim, B.H. (2013) Recent trends in hepatitis B virus infection in the general Korean population. Korean J. Intern. Med., 28, 413-419. DOI |
12 | Kang, H., Roh, H.S., Song, H., Lee, K., Chung, S.T., Ban, S.J., Mo, I.P., An, B.S. and Ahn, C.Y. (2016) Evaluation of haemagglutinin content by RP-HPLC to generate pandemic influenza vaccine. Toxicol. Res., 32, 269-274. DOI |